Close Menu

Rising Costs

It's no secret that pharmaceutical companies are having problems filling their pipelines, says Pharmalot's Ed Silverman. On top of slashing R&D budgets, many companies are now finding that the cost of clinical trials is on the rise, across all phases. "There is increasing competition for trial sites and clinical research organizations that can yield reliable, high quality data," Silverman says.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

UK Royal Statistical Society is organizing a working group to develop guidelines for assessing COVID-19 tests, the Guardian reports.

The Washington Post reports that the White House chief of staff has asked the US Food and Drug Administration to justify the stricter standards it is seeking for a coronavirus vaccine.

President Donald Trump's "good genes" comment raises eugenics concerns, CNN reports.

In PLOS this week: genetic analysis of tremor condition, analysis of a West and Central African tree used in traditional medicine, and more.